DATAVAULT AI INC

Company Overview

Datavault AI Inc. (DVLT) is a small, IP‑centric technology licensing company that has shifted from selling wireless audio hardware toward a software- and blockchain‑enabled Data Sciences suite (Data Vault™) and complementary acoustic/IP platforms following recent IP and asset acquisitions (EOS, Data Vault, CompuSystems). The company’s commercial model is moving to SaaS, licensing, revenue‑sharing and an IDE marketplace that tokenizes data assets across industries (biotech, fintech, hospitality, sports, retail, government), while remaining R&D‑intensive with 36 of ~66 employees in R&D. Financially it remains capital constrained: 2024 revenue was $2.674M with improving gross profit but heavy operating losses and cash burn, and cash fell to ~$0.7M by Q2 2025 amid continuing financings, warrant/convertible mark‑to‑market volatilities and going‑concern disclosures.

Executive Compensation Practices

Given the company’s transition to recurring software/licensing revenue and heavy IP development, executive pay is likely skewed toward equity‑based compensation (stock options, restricted stock, warrants and performance‑based grants) tied to milestones such as IP commercialization, licensing deals, ARR/renewals, and successful integrations of acquisitions. The MD&A explicitly notes higher stock‑based compensation was a material driver of G&A increases, and management judgment over equity‑based expense and warrant/derivative valuations can materially swing reported results — aligning executives’ economic incentives with share price and long‑term monetization of patents and marketplace adoption. Cash salaries may remain modest relative to peers given cash constraints and elevated R&D spend; therefore retention and recruitment are likely managed through acceleration provisions, option refreshes, and milestone pay following financing or licensing events.

Insider Trading Considerations

Insider trading patterns at Datavault AI are likely to be influenced by frequent financing events, warrant and convertible note issuances, and exercises (which create dilution and opportunistic sales), not purely by operating performance; recent reverse splits, additional warrants and notes produced large fair‑value swings that materially affected reported losses. Because executives’ wealth appears concentrated in equity and derivative instruments, watch for option/warrant exercises coinciding with registered offerings, prospectus sales, or immediately after financings when insiders may monetize shares; conversely, lockups and contractual resale restrictions often follow those financings. Regulatory and operational factors — including data‑privacy/cybersecurity compliance, export controls relevant to semiconductor/IP, and SEC Section 16 short‑swing rules or 10b5‑1 plan disclosures — can further shape timing and disclosure of insider transactions, so monitor filings for Form 4s, 10b5‑1 plan notifications, and any insider sales tied to financing or milestone clauses.